# The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis

> **NCT02622386** · PHASE2 · COMPLETED · sponsor: **University of Michigan** · enrollment: 23 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Riboflavin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02622386
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-11
- **Primary completion:** 2020-04-06
- **Final completion:** 2020-04-06
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02622386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02622386, "The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02622386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*